The forecast for ovary malignant neoplasms mortality in the UK from 2024 to 2028 shows a gradual decline in female deaths per hundred thousand women. The value is expected to decrease from 11.4 in 2024 to 11.1 in 2028. This indicates a gentle downward trend in mortality rates over the projected years.

Year-on-year variations: 2025 shows a decrease of 0.9%, 2026 a further decrease of 0.88%, and 2027 a 0.89% decline, with 2028 maintaining the same level as 2027. The five-year compound annual growth rate (CAGR) suggests a consistent 0.66% decline annually. In 2023, the figure stood at 11.5, underscoring a continued reduction over the forecast period.

Future trends to watch for:

Improvements in early detection and treatment methods, potentially accelerating the decline.
Impact of healthcare policies and funding on cancer research and patient support services.
Shifts in lifestyle factors and public health interventions that could influence cancer prevalence.